Sophie Ingrid Hagströmer
Chairman at ALLGON AB (PUBL)
Net worth: 229 401 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Henrik Gustaf Blomquist | M | 53 |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | 25 years |
Max Jonson | M | 56 |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden.
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | 11 years |
Patrik Tigerschiold | M | 60 | 25 years | |
Oskar Hörnell | M | 37 | 9 years | |
Carl Peter Staffan Björkman | M | 54 | 14 years | |
Johanna Sofia von Schéele | F | 37 |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 10 years |
Veronica Byfield Sköld | F | - |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | 3 years |
Jonas Eduard Meerits | M | 50 |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 10 years |
Christoffer Callans | M | - |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 11 years |
Carsten Nils Erik Browall | M | 66 | 5 years | |
Anna Charlotta Falvin | F | 58 | 9 years | |
Ola Samelius | M | - | - | |
Hans Fredrik Mattsson | M | 52 |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | - |
Anders Georg Björkman | M | 69 | 9 years | |
Lars Anders Lindblad | M | 74 |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | 6 years |
Sarah Eddy McPhee | M | 70 | 8 years | |
Jesper Ribbe | M | 52 | - | |
Barry Lian | M | - | - | |
Wilfred de Man | M | - | - | |
Ulrika Ljungkvist | F | - |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | 2 years |
Anna Yvonne Monica Malm Bernsten | F | 63 |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | - |
Ingalill Östman | F | 68 | 8 years | |
Björn Ingemansson | M | 66 | 3 years | |
Philip Nyblaeus | M | 42 | 13 years | |
Jonas Anselmby | M | 56 | - | |
Jörgen Palmhager | M | 56 | 3 years | |
Charlotta Ljungqvist | M | 63 |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | 2 years |
Jane M. Birgitta Stymne Göransson | F | 67 | 2 years | |
Zoran Jankulovski | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jonas Palmquist | M | 49 |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 14 years |
Per Johan Hårdén | M | 48 | 10 years | |
Trolle Sahlström | M | 36 | 6 years | |
Anders Rundgren | M | 58 |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | - |
Svante Andreen | M | 59 |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 3 years |
Daniel Hallberg | M | - |
Scope Capital Advisory AB
Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | 7 years |
Hans Persson | M | - | - | |
Joakim Berlin | M | 49 | - |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sophie Ingrid Hagströmer
- Personal Network